The global total medical aesthetics company Hugel(Chair: Suk-yong Cha) will officially enter the U.S. market through a strategic partnership with the U.S.-based Benev Company.

The company began discussions on a partnership to sell its botulinum toxin product ‘(Letybo, Korean brand name: Botulax)’ in the U.S. in August last year, and finally decided to collaborate with Benev out of a total of 5 companies that had been competing for Hugel’s product.

Established in California in 2000, Benev is an aesthetic company that researches, manufactures, and sells innovative aesthetic medical products such as exosomes, PDO threads, and radiofrequency micro-needles. It is one of the fastes